144 Shares in STERIS plc (NYSE:STE) Bought by Avalon Trust Co

Avalon Trust Co purchased a new stake in STERIS plc (NYSE:STE) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 144 shares of the medical equipment provider’s stock, valued at approximately $30,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Magnolia Capital Advisors LLC boosted its holdings in shares of STERIS by 1.9% in the 4th quarter. Magnolia Capital Advisors LLC now owns 2,534 shares of the medical equipment provider’s stock valued at $521,000 after buying an additional 48 shares during the last quarter. SkyView Investment Advisors LLC lifted its stake in STERIS by 1.6% in the third quarter. SkyView Investment Advisors LLC now owns 3,153 shares of the medical equipment provider’s stock valued at $765,000 after acquiring an additional 51 shares during the last quarter. Park Edge Advisors LLC grew its position in shares of STERIS by 1.1% in the 4th quarter. Park Edge Advisors LLC now owns 4,662 shares of the medical equipment provider’s stock valued at $958,000 after acquiring an additional 51 shares during the period. Citizens Financial Group Inc. RI increased its stake in shares of STERIS by 5.9% during the 4th quarter. Citizens Financial Group Inc. RI now owns 975 shares of the medical equipment provider’s stock worth $201,000 after purchasing an additional 54 shares during the last quarter. Finally, Opal Wealth Advisors LLC raised its holdings in shares of STERIS by 5.7% in the 4th quarter. Opal Wealth Advisors LLC now owns 1,118 shares of the medical equipment provider’s stock valued at $230,000 after purchasing an additional 60 shares during the period. 94.69% of the stock is owned by institutional investors.

STERIS Trading Up 2.1 %

Shares of NYSE:STE opened at $227.04 on Monday. STERIS plc has a 12-month low of $197.82 and a 12-month high of $248.24. The business has a 50 day moving average of $219.17 and a 200-day moving average of $222.38. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32. The stock has a market cap of $22.31 billion, a PE ratio of 48.20 and a beta of 0.92.

STERIS (NYSE:STE) last issued its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. As a group, equities research analysts forecast that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, March 21st. Stockholders of record on Thursday, February 20th will be issued a dividend of $0.57 per share. The ex-dividend date is Thursday, February 20th. This represents a $2.28 annualized dividend and a dividend yield of 1.00%. STERIS’s dividend payout ratio is presently 48.41%.

Analyst Ratings Changes

A number of equities analysts recently commented on the company. JMP Securities reiterated a “market outperform” rating and set a $265.00 price target on shares of STERIS in a report on Thursday, February 6th. Piper Sandler lifted their target price on STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a research note on Monday, February 3rd. Finally, Stephens restated an “overweight” rating and issued a $240.00 price target on shares of STERIS in a research note on Thursday, February 6th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $258.75.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.